UNSPSC 51473018: Benzododecinium chloride

This classification denotes an anti-infective agent with the molecular formula C21H38N.Cl, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y5A751G47H, chemically known as n,n-dimethyl-n-dodecylbenzenemethanaminium chloride but more generally known as benzododecinium chloride, which bears US NIH Compound Identifier 8753. European Medicines Agency schedules Benzododecinium chloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05759MIG.

UNSPSC 51473018 Benzododecinium chloride is a Commodity code for a quaternary ammonium antimicrobial compound that state and local governments procure as a consumable ingredient in janitorial, disinfection, and operational cleaning supplies. Recent activity shows the code appearing in janitorial supply bundles serving public safety and healthcare operations across multiple jurisdictions. County governments and state cooperative purchasing alliances issue the primary solicitations, typically bundling this chemical as part of broader consumables procurement rather than as a standalone item. The work involves supplying authorized, new-condition products with documented chain of custody and recall capabilities, delivered on standard 10-day or emergency 5-day cycles to match the operational schedules of fire rescue departments and healthcare facilities.

The most recent concentration of activity appears in Florida and Minnesota. Hillsborough County Board of County Commissioners posted ITB 2600319 on July 7, 2026 for consumable janitorial and operational supplies (due July 24, 2026) estimated at $765,679.84 for one year, serving the Hillsborough County Fire Rescue Department across 47 fire stations operating 24/7. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802, due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon, with awards effective July 1, 2026 and performance penalties ranging from $200 to $1,500 per violation. Both solicitations require bidders to be authorized distributors or manufacturers with capacity to maintain inventory, supply chain documentation, and compliance with FDA and current Good Manufacturing Practices standards.